View in EDS

Real-world incidence and prevention of tumor lysis syndrome in chronic lymphocytic leukemia treated with venetoclax.

Saved in:

Bibliographic Details
Title:	Real-world incidence and prevention of tumor lysis syndrome in chronic lymphocytic leukemia treated with venetoclax.
Authors:	Valtis YK; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Nemirovsky D; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Derkach A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Sharan S; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Kabel C; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Ortiz R; Department of Medicine, Mount Sinai Morningside-West, New York, NY., Thompson MC; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Roeker LE; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Geyer MB; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Source:	Blood advances [Blood Adv] 2024 Nov 26; Vol. 8 (22), pp. 5806-5813.
Publication Type:	Journal Article; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	2473-9537
DOI:	10.1182/bloodadvances.2024013927